Embecta

Making Medical Affairs a Strategic Pillar

Medical Affairs was historically less established in MedTech than in Pharma, but it has become increasingly important and impactful. Previously, it was largely an executional function supporting products after regulatory approval. Today, it is evolving into a strategic pillar and an equal partner to R&D and Commercial across the product lifecycle—from early development and evidence planning through launch, adoption and post-market evaluation.

As MedTech research and development is often engineering-led, medical affairs provides the clinical perspective needed to connect technical innovation with real-world practice. It brings patient and healthcare professional voices into development, informs intended use and supports solutions that are clinically meaningful, usable and relevant. This transformation is accelerated by the medical device regulation’s stronger clinical-evidence requirements, complex technologies and value-based healthcare. Moreover, as lower-cost alternatives become widely available, innovative devices must demonstrate differentiated clinical value, supported by robust evidence and effective education that enables appropriate adoption and use. Medical Affairs is therefore essential to any responsible MedTech company, regardless of device complexity.

From Evidence to Responsible Innovation

Evidence generation, medical education and cross-functional collaboration create a reinforcing cycle that supports safe and impactful innovation. Clinical studies, real-world evidence and post-market insights show how technologies perform across diverse populations and real-life conditions. These learnings must be brought back into product design to enable continuous lifecycle improvement.

Medical affairs strengthens this process by contributing patient and HCP voices, field insights, and real-world experience. It should advocate for patients and HCPs, ensuring their needs, experiences and workflow realities shape development priorities, evidence strategies, risk assessments and design decisions. Early involvement in engineering-led research and development helps connect technical capabilities with intended use, clinical workflows, safety, usability and meaningful outcomes, helping teams design the right solution, not simply design the solution correctly.

Evidence also informs education that goes beyond product training to support appropriate patient selection, safe adoption, and skilled use. Collaboration with research and development, quality, regulatory, medical safety, commercial and market access ensures that insights return to design and that clinical value is communicated responsibly.

Breaking Silos through Strategic Partnership

My most important leadership lesson is that medical affairs must move from monologue to dialogue. It is not simply a data-dissemination function; it is the organization’s external earpiece, gathering insights from patients, HCPs and the healthcare ecosystem to shape strategy. Breaking down silos and positioning medical affairs as an equal strategic partner are essential to maintaining a coherent, credible scientific voice.

Breaking down silos and positioning medical affairs as an equal strategic partner are essential to maintaining a coherent, credible scientific voice.

Medical affairs should be engaged before major decisions are made, including in product design, human factors, commercial campaigns, education and lifecycle strategy. Early involvement integrates clinical realities and unmet needs while change remains possible, helping teams anticipate risks and communicate responsibly. Human Factors is especially important because MedTech outcomes depend on how products are used in real-life environments, not only on technical performance. Whether Human Factors sits within medical affairs or elsewhere, close medical affairs involvement is critical so usability assessments reflect actual patient experiences, clinical workflows and use-related challenges.

Balancing Innovation with Scientific Trust

Digital transformation offers a major opportunity. There is now an ocean of healthcare data, and AI makes it easier to analyze. Medical affairs is needed to interpret the findings, connect them with clinical practice and turn them into useful evidence and education. Medical Affairs can also combine data with patient engagement to uncover needs, behaviors and challenges, including insights patients themselves may not recognize.

The key challenges are misinformation, data quality, privacy and responsible AI use. Another challenge is that regulatory and evidence standards vary across regions, and some MedTech products may be marketed in parts of the world without meeting the same levels of compliance, clinical evidence or oversight. Medical affairs must therefore remain a trusted scientific voice while ensuring transparency, governance and meaningful patient involvement.

Building an Impactful Medical Affairs Career

Scientific expertise is the ticket for entry, but strategic thinking is perhaps the most important capability for building an impactful medical affairs career. This is rarely a routine, day-to-day role: every day can bring a new question, challenge or priority. That variety can be both rewarding and demanding, requiring creativity, adaptability, sound judgment and comfort with uncertainty.

Professionals must also develop business acumen, digital literacy and data capabilities. They should be able to interpret evidence and explain complex clinical and value information to non-scientific stakeholders.

Above all, a strong sense of purpose matters. Medical affairs professionals should genuinely care about improving healthcare and advocating for patients and HCPs. It is an impactful career that can influence product design, evidence, education and clinical practice—potentially improving the lives of people around the world. You need to enjoy the complexity and constant change, but for the right person, that is also what makes the role meaningful, engaging and fun.